Kalehua Capital Management LLC — 13F Holdings & Portfolio
CIK 2106181 · latest 13F-HR filed 2026-05-15
Kalehua Capital Management LLC manages $141.3M in 13F-reported U.S. long-equity assets across 27 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are XFOR (10.88%), BOXX (9.74%), BOXX (8.22%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 2 new positions, exited 0, added to 8, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$141.3M
Long-equity book
27
Distinct positions
2026-03-31
Filed 2026-05-15
+2 / −0 / ↑8 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- Alpha Architect 1-3 Month Box ETF$11.6M +84.3%
- Veradermics Inc$2.7M +41.6%
- Inhibikase Therapeutics Inc$1.9M +43.0%
- ACLARIS THERAPEUTICS INC$1.9M +37.0%
- Uniqure NV$1.3M +37.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | X4 Pharmaceuticals Inc | XFOR | 98420X202 | $15.4M | 10.88% | 3,722,840 | SH |
| 2 | Alpha Architect 1-3 Month Box ETF | BOXX | 02072L565 | $13.8M | 9.74% | 118,422 | SH |
| 3 | EA SERIES TRUST | BOXX | 02072L565 | $11.6M | 8.22% | 99,856 | SH |
| 4 | Surrozen Inc | SRZN | 86889P208 | $11.2M | 7.94% | 385,178 | SH |
| 5 | Relay Therapeutics Inc | RLAY | 75943R102 | $9.0M | 6.35% | 901,457 | SH |
| 6 | Sionna Therapeutics Inc | SION | 829401108 | $7.9M | 5.59% | 197,072 | SH |
| 7 | ACLARIS THERAPEUTICS INC | ACRS | 00461U105 | $6.9M | 4.86% | 1,832,365 | SH |
| 8 | Veradermics Inc | MANE | 922967104 | $6.5M | 4.60% | 102,879 | SH |
| 9 | Inhibikase Therapeutics Inc | IKT | 45719W205 | $6.4M | 4.54% | 3,821,890 | SH |
| 10 | Oruka Therapeutics Inc | ORKA | 687604108 | $5.8M | 4.11% | 118,524 | SH |
| 11 | Pharvaris NV | PHVS | N69605108 | $5.6M | 3.97% | 198,772 | SH |
| 12 | Uniqure NV | QURE | N90064101 | $4.8M | 3.37% | 291,109 | SH |
| 13 | Septerna Inc | SEPN | 81734D104 | $4.7M | 3.31% | 194,544 | SH |
| 14 | Compass Pathways PLC | CMPS | 20451W101 | $4.5M | 3.21% | 819,692 | SH |
| 15 | LeonaBio Inc | LONA | 04746L203 | $4.0M | 2.86% | 393,701 | SH |
| 16 | Damora Therapeutics Inc | DMRA | 36322Q206 | $3.6M | 2.55% | 139,000 | SH |
| 17 | Gossamer Bio Inc | GOSS | 38341P102 | $3.4M | 2.38% | 10,236,293 | SH |
| 18 | MoonLake Immunotherapeutics | MLTX | 61559X104 | $3.3M | 2.32% | 175,734 | SH |
| 19 | Tyra Biosciences Inc | TYRA | 90240B106 | $2.9M | 2.02% | 74,465 | SH |
| 20 | VERADERMICS INC | MANE | 922967104 | $2.7M | 1.91% | 42,816 | SH |
| 21 | PepGen Inc | PEPG | 713317105 | $1.8M | 1.25% | 1,000,000 | SH |
| 22 | Instil Bio Inc | TIL | 45783C200 | $1.5M | 1.07% | 183,030 | SH |
| 23 | Tenaya Therapeutics Inc | TNYA | 87990A106 | $1.4M | 0.98% | 2,000,000 | SH |
| 24 | KORRO BIO INC | KRRO | 500946108 | $1.2M | 0.88% | 109,376 | SH |
| 25 | Kalaris Therapeutics Inc | KLRS | 482929106 | $782.3K | 0.55% | 135,585 | SH |
| 26 | DiaMedica Therapeutics Inc | DMAC | 25253X207 | $423.0K | 0.30% | 62,488 | SH |
| 27 | LONGEVERON INC | LOOP | 543518104 | $361.4K | 0.26% | 347,539 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $141.3M | 27 | 0002106181-26-000005 |
| 2026-03-31 | 2026-05-15 | $118.6M | 23 | 0002106181-26-000004 |
| 2025-12-31 | 2026-02-13 | $101.1M | 19 | 0002106181-26-000003 |